Brevan Howard Capital Management’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
6,385
-24,175
-79% -$4.18M 0.01% 1013
2026
Q1
$5.17M Buy
30,560
+4,609
+18% +$884K 0.05% 221
2025
Q4
$4.88M Sell
25,951
-8,184
-24% -$1.54M 0.05% 249
2025
Q3
$7.01M Sell
34,135
-32,268
-49% -$6.89M 0.03% 177
2025
Q2
$14.8M Buy
66,403
+39,534
+147% +$8.51M 0.09% 119
2025
Q1
$5.52M Sell
26,869
-6,640
-20% -$1.32M 0.05% 118
2024
Q4
$6.12M Buy
33,509
+7,236
+28% +$1.52M 0.04% 115
2024
Q3
$5.41M Sell
26,273
-29,435
-53% -$5.68M 0.04% 114
2024
Q2
$9.75M Buy
55,708
+43,724
+365% +$7.47M 0.09% 54
2024
Q1
$2.06M Buy
11,984
+676
+6% +$104K 0.02% 146
2023
Q4
$1.7M Buy
+11,308
New +$1.52M 0.02% 138

Other funds holding CTAS

Brevan Howard Capital Management's CTAS Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Cintas (CTAS) stake by 79% in Q2 2026, selling an estimated $4.18M and leaving 6,385 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #1013.

Brevan Howard Capital Management first reported a position in CTAS in Q4 2023 and has held it in 11 quarters since. The position peaked at $14.8M in Q2 2025. 1,432 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • Brevan Howard Capital Management held 6,385 shares of Cintas worth $1.09M as of Q2 2026.
  • Brevan Howard Capital Management sold 24,175 Cintas shares in Q2 2026, an estimated $4.18M.
  • Cintas made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1013 holding.
  • Brevan Howard Capital Management first reported a position in Cintas in Q4 2023 and has held it in 11 quarters since.
  • Brevan Howard Capital Management's Cintas position peaked at $14.8M in Q2 2025.
  • 1,432 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.